Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling
Cells · 2023
DOI: 10.3390/cells12071064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Xiangguo Che und 9 weiteren Autor:innen. Beteiligte Einrichtung: Korea Mouse Phenotyping Center (KMPC), Department of Biochemistry and Cell Biology, Cell and Matrix Research Institute, School of Medicine, Kyungpook…. Hauptthemen laut MEDLINE: Cartilage, Articular, Osteoarthritis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDCR NIH HHS, National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
TGF-β signaling is a vital regulator for maintaining articular cartilage homeostasis. Runx transcription factors, downstream targets of TGF-β signaling, have been studied in the context of osteoarthritis (OA). Although Runx partner core binding factor β (Cbfβ) is known to play a pivotal role in chondrocyte and osteoblast differentiation, the role of Cbfβ in maintaining articular cartilage integrity remains obscure. This study investigated Cbfβ as a novel anabolic modulator of TGF-β signaling and determined its role in articular cartilage homeostasis. Cbfβ significantly decreased in aged mouse articular cartilage and human OA cartilage. Articular chondrocyte-specific Cbfb-deficient mice (Cbfb△ac/△ac) exhibited early cartilage degeneration at 20 weeks of age and developed OA at 12 months. Cbfb△ac/△ac mice showed enhanced OA progression under the surgically induced OA model in mice. Mechanistically, forced expression of Cbfβ rescued Type II collagen (Col2α1) and Runx1 expression in Cbfβ-deficient chondrocytes. TGF-β1-mediated Col2α1 expression failed despite the p-Smad3 activation under TGF-β1 treatment in Cbfβ-deficient chondrocytes. Cbfβ protected Runx1 from proteasomal degradation through Cbfβ/Runx1 complex formation. These results indicate that Cbfβ is a novel anabolic regulator for cartilage homeostasis, suggesting that Cbfβ could protect OA development by maintaining the integrity of the TGF-β signaling pathway in articular cartilage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Korea Mouse Phenotyping Center (KMPC), Department of Biochemistry and Cell Biology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
- Department of Orthopedic Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
- University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
- Department of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
ORCID-Profile: Xiangguo Che, Xian Jin, Na Rae Park, Janet L Stein, Je-Yong Choi
Förderung
- NIAMS NIH HHS
- NIDCR NIH HHS
- National Research Foundation of Korea (NRF)
- Ministry of Education
- Ministry of Science and ICT
- NIDCR
- NIAMS
Zitieren
APA
Che, X., Jin, X., Park, N. R., Kim, H. J., Kyung, H. S., Kim, H. J., Lian, J. B., Stein, J. L., Stein, G. S., & Choi, J. Y. (2023). Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling. Cells. https://doi.org/10.3390/cells12071064
Vancouver
Che X, Jin X, Park NR, Kim HJ, Kyung HS, Kim HJ, et al. Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling. Cells. 2023. doi:10.3390/cells12071064
BibTeX
@article{Che2023,
author = {Che, Xiangguo and Jin, Xian and Park, Na Rae and Kim, Hee-June and Kyung, Hee-Soo and Kim, Hyun-Ju and Lian, Jane B and Stein, Janet L and Stein, Gary S and Choi, Je-Yong},
title = {Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12071064}
}
EUVIMED